TRPV1 and systemic inflammatory response syndrome: Wanner and colleagues showed that TRPV1 antagonism in young (12 wks) mice resulted in increased LPS-induced mortality, demonstrating an anti-inflammatory role for TRPV1 in SIRS [70], supporting earlier work in the CLP sepsis model [69,71,72].